COMPANY INFO
New Lantern is a private company founded in 2021 by Shiva Suri and headquartered in San Francisco, California. It operates in the AI-powered medical imaging industry with approximately 6 employees. The company offers AI-powered medical imaging software designed to assist radiologists by automating repetitive tasks and improving diagnostic efficiency. Its platform includes tools for automated dictation, AI-generated report impressions, smart image segmentation, and adaptive viewing protocols, accessible via their website newlantern.ai.
New Lantern is a private company founded in 2021 by Shiva Suri and headquartered in San Francisco, California. Operating within the Artificial Intelligence (AI), healthcare, and SaaS software industries, New Lantern specializes in AI-powered medical imaging. Their platform provides advanced tools for radiologists including automated dictation, AI-generated report impressions, smart image segmentation, and adaptive viewing protocols, all designed to streamline workflows and improve diagnostic efficiency.
Regarding New Lantern funding, the company has successfully raised a total of $23 million through a single funding round. With its Series A round in 2024 as a major milestone, New Lantern has set a strong financial foundation for accelerating the development and deployment of its AI-driven radiology solutions. The company’s funding strategy has centered on a targeted approach, bringing in renowned venture capital and angel investors with deep expertise in technology and healthcare to support continued R&D and strategic growth.
The Series A round was led by Benchmark and brought in $19 million in funding. The capital will be utilized to launch New Lantern’s AI radiology resident product, fuel further research and development, and grow the company’s engineering and sales teams for broader market reach.
Benchmark is a prominent venture capital firm that led New Lantern’s Series A round. Their involvement brings industry expertise, strategic guidance, and a strong network, supporting New Lantern’s rapid growth and innovation in AI medical imaging.
Afore Capital invests in early-stage technology startups. As a backer of New Lantern, their support provides access to mentorship and expertise in software and AI-driven business models.
Anthology Fund is known for investing in disruptive technology ventures. Their participation in New Lantern’s funding round underscores confidence in the company’s potential within healthcare AI.
Neo is a seed-stage venture capital firm with a focus on startups applying novel technology advancements. Their investment strengthens New Lantern’s technological edge.
SV Angel is a well-regarded seed fund supporting transformative technology companies. As an investor in New Lantern, SV Angel offers value through strategic connections and early-stage growth support.
Guillermo Rauch, founder and CEO of Vercel, brings technical leadership and entrepreneurial experience as an angel investor in New Lantern, adding credibility and insight to the company’s AI and SaaS strategy.
Amjad Masad, founder and CEO of Replit, is a respected technologist and angel investor providing resources and expertise to accelerate New Lantern’s software development and platform efficacy.
As the founder of Benchling, Saji Wickramasekara invests in high-impact tech companies. His input aids New Lantern’s innovation in life sciences and healthcare AI.
Jay Kreps, co-founder and CEO of Confluent, is an angel investor offering key advice on software scaling and enterprise technology integration for New Lantern.
A prominent angel investor and product leader, Gokul Rajaram supports New Lantern by advising on product strategy and growth, leveraging his experience in leading tech companies.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching New Lantern funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.
With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.